Literature DB >> 19903582

The epidemiology of travelers' diarrhea in Incirlik, Turkey: a region with a predominance of heat-stabile toxin producing enterotoxigenic Escherichia coli.

Chad K Porter1, Mark S Riddle, David R Tribble, Shannon D Putnam, David M Rockabrand, Robert W Frenck, Patrick Rozmajzl, Edward Kilbane, Ann Fox, Richard Ruck, Matthew Lim, James Johnston, Emmett Murphy, John W Sanders.   

Abstract

This study evaluated travelers' diarrhea among US military personnel on short-term deployment to Incirlik Air Base, Turkey, from June through September 2002. Upon reporting for care for travelers' diarrhea, subjects were enrolled into the study and completed a series of questionnaires and provided stool specimens for pathogen identification and antimicrobial susceptibility testing. Fifty-three percent of the 202 participating subjects had a pathogen isolated from their stool. Enterotoxigenic Escherichia coli (ETEC) was the predominant pathogen (41%), followed by Campylobacter spp. (12%). The most common ETEC phenotype recovered was stable toxin (ST) CS6 (47% of all ETEC). Most (91.1%) of the cases presented with water diarrhea regardless of isolated pathogen. However, there were some differences in nongastrointestinal symptoms among subjects with Campylobacter spp. All illnesses were well managed with antibiotics with or without loperamide with a median time to the last unformed stool of 9 h (interquartile range, 1-32 h). We found no food or environmental factors associated with a differential risk of infection with a specific pathogen. Travelers' diarrhea among a US military population in and around Incirlik, Turkey, can commonly be attributed to ETEC and Campylobacter spp. The high proportion of ST-only-producing CS6 ETEC in this region highlights the pathogen's worldwide diversity. Future studies of travelers' diarrhea in this population should adapt more novel microbiologic techniques such as polymerase chain reaction and enhanced culture methods to increase the likelihood of identifying pathogenic E. coli. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19903582     DOI: 10.1016/j.diagmicrobio.2009.10.002

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  11 in total

1.  New Developments in Traveler's Diarrhea.

Authors:  Javier de la Cabada Bauche; Herbert L Dupont
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-02

2.  Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans.

Authors:  David R Tribble; Shahida Baqar; Daniel A Scott; Michael L Oplinger; Fernando Trespalacios; David Rollins; Richard I Walker; John D Clements; Steven Walz; Paul Gibbs; Edward F Burg; Anthony P Moran; Lisa Applebee; A Louis Bourgeois
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

Review 3.  Resistant pathogens as causes of traveller's diarrhea globally and impact(s) on treatment failure and recommendations.

Authors:  David R Tribble
Journal:  J Travel Med       Date:  2017-04-01       Impact factor: 8.490

4.  Occupations at risk of contracting zoonoses of public health significance in Québec.

Authors:  Ariane Adam-Poupart; Laurie-Maude Drapeau; Sadjia Bekal; Geneviève Germain; Alejandra Irace-Cima; Marie-Pascale Sassine; Audrey Simon; Julio Soto; Karine Thivierge; France Tissot
Journal:  Can Commun Dis Rep       Date:  2021-01-29

5.  Oral delivery of Hyperimmune bovine serum antibodies against CS6-expressing enterotoxigenic Escherichia coli as a prophylactic against diarrhea.

Authors:  K R Talaat; C K Porter; A L Bourgeois; T K Lee; C A Duplessis; M Maciel; R L Gutierrez; B DeNearing; B Adjoodani; R Adkinson; K J Testa; B Feijoo; A N Alcala; J Brubaker; A Beselman; S Chakraborty; D Sack; J Halpern; S Trop; H Wu; J Jiao; E Sullivan; M S Riddle; S S Joseph; S T Poole; M G Prouty
Journal:  Gut Microbes       Date:  2020-03-13

Review 6.  Travel-Related Antimicrobial Resistance: A Systematic Review.

Authors:  Hamid Bokhary; Krisna N A Pangesti; Harunor Rashid; Moataz Abd El Ghany; Grant A Hill-Cawthorne
Journal:  Trop Med Infect Dis       Date:  2021-01-16

7.  An Evidenced-Based Scale of Disease Severity following Human Challenge with Enteroxigenic Escherichia coli.

Authors:  Chad K Porter; Mark S Riddle; Ashley N Alcala; David A Sack; Clayton Harro; Subhra Chakraborty; Ramiro L Gutierrez; Stephen J Savarino; Michael Darsley; Robin McKenzie; Barbara DeNearing; Hans Steinsland; David R Tribble; A Louis Bourgeois
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

8.  A cross-sectional analysis of clinical presentations of and risk factors for enteric protozoan Infections in an Active Duty Population during Operation Iraqi Freedom.

Authors:  John W Downs; Mark S Riddle; Shannon D Putnam; David M Rockabrand; Gamal El Okla; Manal Mostafa; Marshal R Monteville; Louis E Antosek; James Herbst; David R Tribble; John W Sanders
Journal:  Trop Dis Travel Med Vaccines       Date:  2015-07-31

9.  Travelers' diarrhea: update on the incidence, etiology and risk in military and similar populations - 1990-2005 versus 2005-2015, does a decade make a difference?

Authors:  Scott Olson; Alexis Hall; Mark S Riddle; Chad K Porter
Journal:  Trop Dis Travel Med Vaccines       Date:  2019-01-15

Review 10.  Extended-spectrum beta-lactamase-producing strains among diarrhoeagenic Escherichia coli-prospective traveller study with literature review.

Authors:  Anu Kantele; Tinja Lääveri
Journal:  J Travel Med       Date:  2022-01-17       Impact factor: 8.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.